SAN FRANCISCO, Aug. 3, 2021 / PRNewswire / – A new market study published through Global Industry Analysts Inc. , (GIA), the leading market research company, published its report titled “Neuromodulation – Global Market Trajectory”
MADE IN A BLINK OF ILEEDITION: 8; Launch: May 2021 Executive Group: 10472 Company: 83 – Covered players come with Abbott Laboratories; Aleva Neurotherapeutics SA; BioControl Medical; Bioness Inc; Boston Scientific Society; Cefaly; electroCore, Inc. ; Inspire Medical Systems, Inc. ; LivaNova SA; Medtronic; Neuronetics; NeuroPace, Inc. ; NeuroSigma, Inc. ; Nevro Company; Respicardia, Inc; Stimwave LLC; Synapse Biomedical, Inc. and others. Coverage: All primary geographic spaces and key segments Segments: Technology (spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, transcutaneous electrical nerve stimulation, repetitive transcranial magnetic stimulation, other technologies); Application (chronic pain, back failure syndrome, depression, epilepsy, Parkinson’s disease, migraine, other applications) Geographies: world; UNITED STATES; Canada; Japan; Porcelain; Europe; La France; Germany; Italy; UNITED KINGDOM; The rest of Europe; Asia-Pacific; Rest of the world.
Free project overview: This is a continuous global program. Anticipate our curriculum before making an acquisition decision. We offer free access to executives qualified in strategy rate, business development, sales and marketing and product control in the decided companies. provide privileged access to business trends; competing brands; profiles of experts in the field; and models of market knowledge and much more. You can also create your own tradition report on our MarketGlass ™ platform, which offers thousands of bytes of knowledge without wanting to acquire our report.
ABSTRACT-
The global neuromodulation market will succeed in $8. 2 billion through 2026 neuromodulation paints through active nerve stimulation to generate a biological reaction or by direct application of pharmaceutical agents targeted in small doses to the domain of action. or peripheral nerves. The expansion of the global market is fueled by a growing number of people suffering from diseases such as urinary incontinence, Parkinson’s disease, spinal cord injuries, migraine and epilepsy. awareness of neurodegenerative and neurological disorders and expansion of application domains. The increasing onset of depression and its related symptoms, especially among millennials, opens up new opportunities. The growing awareness of the efficacy and protection of neurostimulation devices is contributing to the expansion of the market.
Amid the COVID-19 crisis, the estimated US $ 5. 1 billion global neuromodulation market in 2020 is expected to succeed at a revised US $ 8. 2 billion spread through 2026, developing at a CAGR of 8. 2% during the investigation period. Spinal cord stimulation, one of the segments analyzed in the report, is expected to grow at a CAGR of 8. 3% to $ 3. 9 billion through the end of the investigation period. After a thorough investigation of the business implications of the pandemic and induced economic crisis, the expansion of the deep brain stimulation segment is readjusted to a revised CAGR of 8. 6% for the next 7 years. This segment lately represents a 16. 7% share of the global neuromodulation market. The Spinal Cord Stimulation (SCS) segment is making significant strides, thanks to the wide availability of a wide variety of advertising SCS products and the growing diversity of programs for those devices. SCS systems are used in neurological disorders such as arachnoiditis, neuropathy, neuritis, nerve damage, back surgery-like disorders, and complex regional pain syndrome. Deep brain stimulation is expected to delight in tremendous expansion, due to its use in the remedy of various neurological conditions such as depression, tremors, Parkinson’s disease, and others. The DBS strategy is already approved through the US FDA for the treatment of obsessive compulsive disorder, dystonia, essential tremors, epilepsy, and Parkinson’s disease.
The US Laceplaceplaceplace market is estimated to be $ 2. 6 billion in 2021, while China is expected to be successful at $ 597. 6 million through 2026. The neuromodulation marketplaceplaceplaceplace market in the United States is estimated at $ 2. 6 billion in 2021. The country lately accounts for 48. 43% percentage of Array China, the world’s second-largest economy, is expected to succeed in an estimated length of market acceptance in the market of US $ 597. 6 million in 2026, with a compound annual rate of 10% during the study period. Other prominent locations in the geographic market are Japan and Canada, each forecasting expansion of 7. 9% and 8. 4%, respectively, over the study period. In Europe, Germany is expected to grow by around 7. 5% CAGR, while the rest of the European market, as explained in the study, will be successful at $ 663. 5 million until the end of the study period. , driven by technological advancements and significant investments made through primary corporations in product development. In addition to the increasing emergence of neurological diseases and the expansion of the geriatric population, the increase in finishes in the fitness sector, the positive reimbursement framework and the presence of several primary industry players in the region are driving the market expansion. A highly evolved healthcare infrastructure, increasing disease prevalence, and expanding approvals for non-invasive devices in Europe have created a growing demand for these devices. Growth in the Asia-Pacific region is supported by a high prevalence of neurological disorders, ongoing study activities, the expansion of investments by personal and public actors, and the expansion of projects to improve awareness of intellectual fitness. .
Sacral nerve stimulation segment will succeed by $1. 2 billion through 2026 In the global sacral nerve stimulation segment, the United States, Canada, Japan, China and Europe will lead to the estimated growth rate of 7. 3% for this segment. of US$696. 3 million in 2020 will succeed in a projected duration of US$1. 1 billion until the end of the IP. China will continue to be one of the fastest developing countries in this organization of regional market places. Korea, the Asia-Pacific market, is expected to succeed by $70. 2 million by 2026.
MarketGlass platform ™ Our MarketGlass ™ platform is a comprehensive and comprehensive knowledge medium that can be configured to meet the intelligence desires of today’s busy business leaders!exclusive perspectives of the participation of leaders from all over the world. Features come with: peer-to-peer collaborations across the enterprise; overviews of the study systems applicable to your business; 3. 4 million profiles of experts in the box; competitive business profiles; interactive search modules; Customized reports monitor market trends; competing brands; create and publish blogs and podcasts our number one and secondary content; Tracking of dominance occasions around the world; and much more. Corporate consumers will have full internal access to the project’s knowledge stacks. Currently used through more than 67,000 experts in the box worldwide.
Our platform is loose for qualified executives and is available on our online page www. StrategyR. com or our mobile app that has just been released on iOS or Android.
About Global Industry Analysts, Inc. et StrategyR ™ Global Industry Analysts, Inc. , (www. strategyr. com) is a famous publisher of Workplace Market Research, the market place research firm focused on influencers around the world. Countries, GIA has been identified by its market accuracy, place of exchange and industry forecast for over 33 years.
CONTACTS: Zak AliDirector, Corporate CommunicationsGlobal Industry Analysts, Inc. Phone: 1-408-528-9966www. StrategyR. com Email: ZA@StrategyR. com
LINKS Join our panel of experts https://www. strategyr. com/Panelist. asp
Connect with us on LinkedIn https://www. linkedin. com/company/global-industry-analysts-inc. /
Follow us on Twitterhttps: //twitter. com/marketbytes
journalists
View the content to download the media: https://www. prnewswire. com/news-releases/global-neuromodulation-market-to-reach-8-2-billion-by-2026–301345914. html
SOURCE Global Industry Analysts, Inc.